Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma

Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today...

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltène

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co., Ltd.) has announced the completion of its acquisition of Foltene, a dermatological hair care brand from Italy. Products of...

Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis

Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies,...

HJT Everywhere: Huasun Demonstrates Flexible PV Integration from Balconies to Electric Vehicles at SNEC 2025

HJT Everywhere: Huasun Demonstrates Flexible PV Integration from Balconies to Electric Vehicles at SNEC 2025

SHANGHAI, June 18, 2025 /PRNewswire/ -- Huasun Energy, the world's leading heterojunction (HJT) solar technology provider, launched three astonishing new products to push the limits of solar application on the first day of SNEC PV Power Expo 2025 in...

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for...

TCL Solar Showcases Next-Gen BC Modules at SNEC, Writing the Future of Solar Innovation with Technological Advancements

TCL Solar Showcases Next-Gen BC Modules at SNEC, Writing the Future of Solar Innovation with Technological Advancements

SHANGHAI, June 13, 2025 /PRNewswire/ -- From June 11th to 13th, the 18th International Solar Photovoltaic and Smart Energy Conference & Exhibition (SNEC PV+ 2025) was held at the National Exhibition and Convention Center in Shanghai. During the...

The GrowHub Announces Expansion of Research & Development Team to Accelerate AI Development and Capabilities

The GrowHub Announces Expansion of Research & Development Team to Accelerate AI Development and Capabilities

SINGAPORE, June 4, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity for products along the entire supply chain,...

The GrowHub Partners with Business Engineers Asia to Deliver its Traceability Solution

The GrowHub Partners with Business Engineers Asia to Deliver its Traceability Solution

SINGAPORE, May 21, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity, partners with Business Engineers Asia ("BEA")...

THE GROWHUB LIMITED to Present at the 4th World Digital Economy & Technology Summit 2025

THE GROWHUB LIMITED to Present at the 4th World Digital Economy & Technology Summit 2025

SINGAPORE, May 14, 2025 /PRNewswire/ -- THE GROWHUB LIMITED ("The GrowHub" or the "Company"), a Singapore-based company leveraging blockchain technology to enhance product traceability and authenticity, will be presenting at the 4th World Digital...

ICAC Commissioner concludes mission to three ASEAN member countries with fruitful results

ICAC Commissioner concludes mission to three ASEAN member countries with fruitful results

HONG KONG, May 9, 2025 /PRNewswire/ -- ICAC Commissioner Mr Woo Ying-ming concluded a seven-day duty visit to three member states of the Association of Southeast Asian Nations (ASEAN), i.e., Brunei Darussalam, Singapore and Indonesia in early May....

  • 1
  • 2
  • menu
    menu